NCT02286518View on ClinicalTrials.gov

TAK-114 Single- and Multiple-Dose Phase 1 Study

PHASE1CompletedINTERVENTIONAL

Enrollment

82

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

April 30, 2015

Study Completion Date

April 30, 2015

Conditions

Clinical Pharmacology

Interventions

DRUG

TAK-114 10 mg capsule

DRUG

TAK-114 matched placebo

Trial Locations (1)

Unknown

Sumida-ku

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Takeda

INDUSTRY